Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin containing chemotherapy
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2618642
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: CPT-11 150mg/m2(day1) Capecitabine Xmg/m2, p.o.(day2-8) to be repeated every 2 weeks for four course
Primary outcome(s): Dose limiting toxicity, safety
Study Design: Single arm Non-randomized
创建时间：
2010-02-15
